A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
Titel:
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
Auteur:
Cullen, M.H. Zatloukal, P. Sörenson, S. Novello, S. Fischer, J.R. Joy, A.A. Zereu, M. Peterson, P. Visseren-Grul, C.M. Iscoe, N.